Damora Therapeutics (DMRA) Payables (2019 - 2026)
Damora Therapeutics (DMRA) reported Payables of $3.48 million for Q2 2026, up 360.6% from $756,000 a year earlier and up 325.2% from the prior quarter.
Powered by 
Analysis
Damora Therapeutics (DMRA) Payables (2019 - 2026) Analysis & Trends
At the end of FY2025, Damora Therapeutics posted Payables of $444,000, up 17.8% from FY2024.
- Payables has a five-year compound annual growth rate of -31.1% (FY2020 to FY2025).
- By year, Payables came in at $377,000 in FY2024 (-77.8%), $1.7 million in FY2023 (-49.2%), $3.35 million in FY2022 (+118.8%) and $1.53 million in FY2021 (-46.3%).
- The Q2 2026 figure ranks as the highest quarterly Payables since Q3 2023.
- Year over year, Payables has now increased in each of the last five quarters, with growth averaging 34.0% over the last eight quarters.
- The high point for year-over-year Payables in five years was Q2 2026 (growth of 360.6%); the low point was Q3 2024 (a decline of 88.8%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $819,000 (Q1 2026), $444,000 (Q4 2025) and $520,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 20.92 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 33.30 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 5.96 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 4.26 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -22.89 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 2.87 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 674.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 7.03 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 429.50 Mn |
| 10 | Damora Therapeutics | 1.28 Bn | -57.65 Mn | - | 3.48 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.48 Mn |
| Mar 31, 2026 | 819,000.00 |
| Dec 31, 2025 | 444,000.00 |
| Sep 30, 2025 | 520,000.00 |
| Jun 30, 2025 | 756,000.00 |
| Mar 31, 2025 | 354,000.00 |
| Dec 31, 2024 | 377,000.00 |
| Sep 30, 2024 | 503,000.00 |
| Jun 30, 2024 | 724,000.00 |
| Mar 31, 2024 | 1.67 Mn |
| Dec 31, 2023 | 1.70 Mn |
| Sep 30, 2023 | 4.48 Mn |
| Jun 30, 2023 | 5.56 Mn |
| Mar 31, 2023 | 3.55 Mn |
| Dec 31, 2022 | 3.35 Mn |
| Sep 30, 2022 | 1.91 Mn |
| Jun 30, 2022 | 2.82 Mn |
| Mar 31, 2022 | 3.22 Mn |
| Dec 31, 2021 | 1.53 Mn |
| Sep 30, 2021 | 1.98 Mn |
API Access
Damora Therapeutics Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=payables&ticker=DMRA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "payables", "ticker": "DMRA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=payables&ticker=DMRA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();